325 related articles for article (PubMed ID: 35624326)
1. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 4 L, 2 L, and 1 L PEG bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study.
Dai C; Tian W; Huang YH; Jiang M
Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882178
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
[TBL] [Abstract][Full Text] [Related]
4. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.
Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082
[TBL] [Abstract][Full Text] [Related]
5. Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study.
Seishima R; Okabayashi K; Ikeuchi H; Uchino M; Futami K; Noguchi T; Ohge H; Iseki Y; Watanabe K; Itabashi M; Okamoto K; Toiyama Y; Ogino T; Nakamura M; Yamada K; Wakai T; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Ishida F; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Yamamoto S; Hanai T; Maemoto A; Arakaki J; Komori K; Akagi Y; Shida D; Yamaguchi S; Matsuda K; Maeda K; Noake T; Nezu R; Sasaki S; Hasegawa J; Sunami E; Kanemitsu Y; Katsumata K; Uehara K; Kiyomatsu T; Suto T; Kazama S; Yamada T; Goi T; Ishihara S; Ajioka Y; Sugihara K
Am J Gastroenterol; 2023 Jul; 118(7):1248-1255. PubMed ID: 36622356
[TBL] [Abstract][Full Text] [Related]
6. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
[TBL] [Abstract][Full Text] [Related]
7. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Gu P; Luo J; Kim J; Paul P; Limketkai B; Sauk JS; Park S; Parekh N; Zheng K; Rudrapatna V; Syal G; Ha C; McGovern DP; Melmed GY; Fleshner P; Eisenstein S; Ramamoorthy S; Dulai PS; Boland BS; Grunvald E; Mahadevan U; Ohno-Machado L; Sandborn WJ; Singh S
Am J Gastroenterol; 2022 Oct; 117(10):1639-1647. PubMed ID: 35973139
[TBL] [Abstract][Full Text] [Related]
8. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
[TBL] [Abstract][Full Text] [Related]
9. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
10. Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease.
Zubrzycka I; Bogale K; Stuart A; Cesaire M; Walter V; Dalessio S; Tinsley A; Williams E; Clarke K; Coates MD
Int J Colorectal Dis; 2023 Aug; 38(1):213. PubMed ID: 37578543
[TBL] [Abstract][Full Text] [Related]
11. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
Cai Q; Ding Z; Fu AZ; Patel AA
BMC Gastroenterol; 2022 Dec; 22(1):545. PubMed ID: 36581802
[TBL] [Abstract][Full Text] [Related]
12. Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score-matched analysis of US nationwide inpatient sample 2016-2018.
Zheng WW; Zhou Q; Xue ML; Yu X; Chen JT; Ao L; Wang CD
J Dig Dis; 2023 Nov; 24(11):572-583. PubMed ID: 37823607
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease.
Gordon BL; Galati JS; Yang S; Longman RS; Lukin D; Scherl EJ; Battat R
World J Gastroenterol; 2022 Sep; 28(33):4834-4845. PubMed ID: 36156920
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O
J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388
[TBL] [Abstract][Full Text] [Related]
15. Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis.
Osman KT; Hoque A; Pasam RT; Farhoud A; Abdelfattah A; Ramadorai V; Chaudrey K; Pellish R
BMC Gastroenterol; 2023 May; 23(1):171. PubMed ID: 37217857
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic scoring system utilization for inflammatory bowel disease activity assessment: A multicenter real-world study from Argentina.
Lasa J; Smolarczuk A; Navar S; Ponce C; Galvarini M; Orellana D; Caruso E; Espinosa F; Meligrana N; Rainero G; Correa G; Yantorno M; Garbi M; Giraudo F; Martínez S; García L; Marceno F; Marturano V; Reyes K; Steinberg L; Pereyra L; Olivera P
Gastroenterol Hepatol; 2024 Mar; 47(3):253-261. PubMed ID: 37330213
[TBL] [Abstract][Full Text] [Related]
17. Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
Iacucci M; Jeffery L; Acharjee A; Grisan E; Buda A; Nardone OM; Smith SCL; Labarile N; Zardo D; Ungar B; Hunter S; Mao R; Cannatelli R; Shivaji UN; Parigi TL; Reynolds GM; Gkoutos GV; Ghosh S
Inflamm Bowel Dis; 2023 Sep; 29(9):1409-1420. PubMed ID: 36378498
[TBL] [Abstract][Full Text] [Related]
18. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
Vega P; Huguet JM; Gómez E; Rubio S; Suarez P; Vera MI; Paredes JM; Hernández-Camba A; Plaza R; Mañosa M; Pajares R; Sicilia B; Madero L; Kolterer S; Leitner C; Heatta-Speicher T; Michelena N; Santos de Lamadrid R; Dignass A; Gomollón F
Dig Dis Sci; 2024 Mar; 69(3):749-765. PubMed ID: 38217680
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review.
Pal P; Pooja K; Nabi Z; Gupta R; Tandan M; Rao GV; Reddy N
Indian J Gastroenterol; 2024 Feb; 43(1):172-187. PubMed ID: 38418774
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case-Control Study.
Bezzio C; Schettino M; Manes G; Andreozzi P; Arena I; Della Corte C; Costetti M; Devani M; Omazzi BF; Saibeni S
Crohns Colitis 360; 2020 Oct; 2(4):otaa077. PubMed ID: 36777747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
